Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Using electroconvulsive therapy for patients with neurological disease.

Hospital & Community Psychiatry

|August 1, 1986

Summary

Electroconvulsive therapy (ECT) can be safely used for patients with major depression and central nervous system disorders. This treatment offers benefits for both depression and organic mental syndromes, despite potential risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Massive graviton as a testable cold-dark-matter candidate.

Physical review letters·2005

Same author

Rapid cycling bipolar disease: new concepts and treatments.

Current psychiatry reports·2001

Same author

Nicardipine improves the antidepressant action of ECT but does not improve cognition.

The journal of ECT·2001

Same author

Treatment resistance in anxiety disorders.

Bulletin of the Menninger Clinic·2000

Same author

Statistics of clustering of ultrahigh energy cosmic rays and the number of their sources.

Physical review letters·2000

Same author

Are antidepressants addictive?

Health news (Waltham, Mass.)·2000

Area of Science:

Neuroscience
Psychiatry
Neurology

Background:

Electroconvulsive therapy (ECT) is underutilized in the United States for patients with central nervous system (CNS) disorders.
Clinicians may lack awareness regarding the safe application of ECT in complex patient populations.
ECT is indicated for psychiatric disorders that are exacerbated by or mimic brain disease.

Observation:

This review examines the safe and effective use of ECT in patients with co-occurring major depression and CNS conditions.
Case examples illustrate successful ECT application in patients with organic mental syndromes, including delirium.
Potential risks associated with ECT are discussed alongside its therapeutic benefits.

Findings:

ECT has demonstrated safety and efficacy in treating patients with combined major depression and CNS disorders.
The treatment is effective for psychiatric conditions influenced by underlying brain pathology.
Worldwide experience and case studies support the use of ECT in these complex cases.

Implications:

Findings suggest a broader role for ECT in managing psychiatric conditions with comorbid neurological or organic mental syndromes.
Understanding potential benefits and risks can guide clinical decision-making for ECT in specific patient groups.
Further research into the mechanisms of ECT may elucidate its effects on both mood and cognitive function.

Related Experiment Videos